Equity Research

Capital ideas from the industry’s brightest minds.

Our award-winning equity research analysts deliver superior investment ideas and value-added perspective for nearly 650 companies, across seven growth-oriented sectors: consumer; energy and sustainability; financial services and technology; industrials; global services; healthcare; and technology, media, and communications. William Blair’s research universe is diversified across multiple industry verticals and a wide range of market capitalization, with an emphasis on quality business models in their emerging growth phase of development.

~650

companies under
research coverage
75%+

of coverage dedicated to small- and mid-cap growth companies
100+

analysts and research
professionals

As of March 31, 2025

William Blair analysts seek to cover only companies that have above-average growth prospects and above-average quality. They use multiple factors to identify high-quality companies with attractive growth prospects, including the company’s product line, level of service, and management experience.

Our clients include:

Mutual Funds
Investment Advisory Firms
Banks
Pension Funds
Insurance Companies
Money Managers Across North America, Europe, and Asia

Through exhaustive fundamental research and unique insight derived from independent thinking, our award-winning analysts work tirelessly to identify companies that can deliver superior investment returns for our clients.

Recent News

Monday, May 5, 2025

Roper Technologies, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Roper Technologies, Inc. (ROP $557.59), a leading operator and acquirer of high-quality vertical software assets across multiple industries.
Read more
Monday, April 21, 2025

Zillow Group, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Zillow Group, Inc. (Z $62.47), the leader among home search portals in visitor traffic.
Read more
Monday, April 21, 2025

William Blair Initiates Coverage of Two Biotech Companies

William Blair initiated research coverage of Context Therapeutics Inc. (CNTX $0.84) and Xencor, Inc. (XNCR $9.70), two biotech companies focused on the development of T-cell engagers (TCEs) for solid tumor indications.
Read more

See more news

William Blair Thinking Podcast

Navigating the current market environment demands the right informational resource. That is why we launched the William Blair Thinking Podcast, which aims to provide in-depth expertise on today's financial and economic landscape.

What's different about this platform?
It's our most timely and best ideas—the ethos, if you will, of our firm's intellectual capital. All in 20 minutes.
Our latest podcasts
William Blair Shines in 2024 Coalition Greenwich Study with 12 No. 1 Rankings

William Blair, the premier global partnership with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.
Learn more

Featured Insights

Friday, May 9, 2025

Economics Weekly: The Dollar Dilemma

While further softening in the exchange rate is expected, in this Economics Weekly, Richard de Chazal discusses why the U.S. is likely still unable to shed its exorbitant privilege and reserve currency status anytime soon, even if there are many reasons to think it might want to.
Read more
Tuesday, May 6, 2025

Cash is Still King, Especially During the Great Iberian Blackout (El Apagón)

The complete power outage across the Iberian Peninsula last week was a wake-up call. William Blair’s Richard de Chazal outlines five lessons to take away from the event.
Read more
Friday, May 2, 2025

Economics Weekly: From Growth to GARP

In this Economics Weekly, Richard de Chazal discusses the shift from low, stable inflation to a more volatile regime and its implications for investors, including a potential move from growth investing to GARP (growth at a reasonable price) investing.
Read more